A previous study also detected a dramatic reduction in the number of pancreatic cancer cells with podosomal rosettes after ezrin RNAi treatment and reported that formation of podosomes and their rosettes was driven by an ezrin–cortactin interaction, which has a role in pancreatic cancer invasion [44]. The gene discussed is CTTN; the disease is pancreatic neoplasm.